AIM ImmunoTech, Inc. (AIM)

1.195 -0.06 (-5.16%) USD  |  NYAM  |  Jan 23, 14:35
More

AIM ImmunoTech Minority Interest Ownership (Quarterly)

Minority Interest Ownership (Quarterly) Chart

View Minority Interest Ownership (Quarterly) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Minority Interest Ownership (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Minority Interest Ownership (Quarterly) Range, Past 5 Years

View Minority Interest Ownership (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Minority Interest Ownership (Quarterly) Benchmarks

View Minority Interest Ownership (Quarterly) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade